These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 6147846)
1. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing. Luscombe DK Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846 [TBL] [Abstract][Full Text] [Related]
2. Relative bioavailability in humans for oral tablets and solutions of lormetazepam. Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762 [TBL] [Abstract][Full Text] [Related]
3. [The pharmacokinetics of lormetazepam following cimetidine]. Doenicke A; Dorow R; Täuber U Anaesthesist; 1991 Dec; 40(12):675-9. PubMed ID: 1685875 [TBL] [Abstract][Full Text] [Related]
4. A new lormetazepam galenical formulation for sublingual premedication. Van Boven MJ; Scholtes JL; Collard E; Van Obbergh L; Gribomont BF Acta Anaesthesiol Belg; 1988; 39(4):233-7. PubMed ID: 2906778 [TBL] [Abstract][Full Text] [Related]
5. Relationship between EEG dynamics and pharmacokinetics of the benzodiazepine lormetazepam. Kurowski M; Ott H; Herrmann WM Pharmacopsychiatria; 1982 May; 15(3):77-83. PubMed ID: 6124982 [TBL] [Abstract][Full Text] [Related]
6. Alprazolam kinetics following sublingual and oral administration. Scavone JM; Greenblatt DJ; Shader RI J Clin Psychopharmacol; 1987 Oct; 7(5):332-4. PubMed ID: 3680603 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacokinetics and pharmacodynamics of verapamil in healthy volunteers after single oral and sublingual administration]. Woodcock BG; Wörner P; Rietbrock N; Schwabe L; Frömming KH Arzneimittelforschung; 1982; 32(12):1567-71. PubMed ID: 6891597 [TBL] [Abstract][Full Text] [Related]
8. [Plasma concentration and amnesia following lormetazepam and flunitrazepam in i.v. premedication]. Heipertz W; Vontin H; Hempel V; Eichinger V Anasth Intensivther Notfallmed; 1986 Jun; 21(3):113-6. PubMed ID: 3752422 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic correlates of modified absorption: studies with lormetazepam. Pierce DM; Franklin RA; Harry TV; Nicholson AN Br J Clin Pharmacol; 1984 Jul; 18(1):31-5. PubMed ID: 6146348 [TBL] [Abstract][Full Text] [Related]
10. Minimal biliary excretion and enterohepatic recirculation of lormetazepam in man as investigated by a new nasobiliary drainage technique. Hellstern A; Hildebrand M; Hümpel M; Hellenbrecht D; Saller R; Madetzki C Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):256-61. PubMed ID: 1973917 [TBL] [Abstract][Full Text] [Related]
11. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial. Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608 [TBL] [Abstract][Full Text] [Related]
12. [Preoperative anxiolysis with lormetazepam. A model for measuring anxiety]. Ulsamer B; Doenicke A; Ott H; Suttmann H Anaesthesist; 1983 Jun; 32(6):304-12. PubMed ID: 6137167 [TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and biotransformation of the new benzodiazepine lormetazepam in humans. I. Absorption, distribution, elimination and metabolism of lormetazepam-5-14C. Hümpel M; Illi V; Milius W; Wendt H; Kurowski M Eur J Drug Metab Pharmacokinet; 1979; 4(4):237-43. PubMed ID: 43806 [TBL] [Abstract][Full Text] [Related]
14. Plasma concentrations following oral and sublingual administration of lorazepam. Gram-Hansen P; Schultz A Int J Clin Pharmacol Ther Toxicol; 1988 Jun; 26(6):323-4. PubMed ID: 3410611 [TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial comparing doses and efficacy of lormetazepam tablets or oral solution for insomnia in a general practice setting. Ancolio C; Tardieu S; Soubrouillard C; Alquier C; Pradel V; Micallef J; Blin O Hum Psychopharmacol; 2004 Mar; 19(2):129-34. PubMed ID: 14994324 [TBL] [Abstract][Full Text] [Related]
16. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans. Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700 [TBL] [Abstract][Full Text] [Related]
17. Controlled comparison of a new sublingual lormetazepam formulation and i.v. diazepam in outpatient minor oral surgery. O'Boyle CA; Barry H; Fox E; McCreary C; Bewley A Br J Anaesth; 1988 Mar; 60(4):419-25. PubMed ID: 2895664 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk. Hümpel M; Stoppelli I; Milia S; Rainer E Eur J Clin Pharmacol; 1982; 21(5):421-5. PubMed ID: 6122580 [TBL] [Abstract][Full Text] [Related]
19. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [TBL] [Abstract][Full Text] [Related]
20. Plasma levels and urinary excretion of lormetazepam in patients with liver cirrhosis and in healthy volunteers. Hildebrand M; Hellstern A; Hümpel M; Hellenbrecht D; Saller R Eur J Drug Metab Pharmacokinet; 1990; 15(1):19-26. PubMed ID: 1974495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]